Thyroid hormone for Bipolar Disorder: Is it Really Groundbreaking?

Thyroid hormone for Bipolar Disorder: Is it Really Groundbreaking?

Thyroid hormone for Bipolar Disorder: Is it Really Groundbreaking?

Thyroid hormone for Bipolar Disorder: Is it Really Groundbreaking? Too early to tell. Need other researchers to to confirm before you quit your bipolar drugs and take big doses of T4!

DR.Guttler opinion on this article.

  1. Precision medicine, the breakthrough effectively predicts and targets the treatment of patients based on their genetic profile.
  2. A combination of rTMS (Repetitive Transcranial Magnetic Stimulation)my00185_im00182_mcdc7_tms_jpg
  3. and high dose of thyroid hormone,_
  4. alongside targeted genetic testing for thyroid activating enzymes which ensures the patient suffers minimal, if any side effects.
  5. 90% of the bipolar cases randomly and consecutively tested have a deficiency of one, two or both enzymes needed to activate thyroid hormone in the brain and the body.
  6. High dose thyroid hormone to specifically target in those sufferers who lack the activating enzymes Deiodinase 1 and Deiodinase 2.
  7. These patients are unable to activate normal doses of thyroid hormone.
  8. The team found that as a result, they can be treated with minimal or no side effects with high dose thyroid and rTMS.
  9. Some may need one additional drug as opposed to the usual requirement of a standard of 3 to 4 drugs which, as a rule, cause significant side effects.
  10. Patients saw their condition recover fully after years of unsuccessful treatment with drugs, with the age ranges of patients being between 15 and 80-years-old.
  11. Sounds great but wait and see.

Groundbreaking discovery in bipolar disorder treatment could change lives of millions forever

The London Psychiatry Centre – which operates a clinic in Newcastle – unveiled the exciting discovery in Cape Town, South Africa, on Sunday.

A groundbreaking discovery which could change the lives of millions of bipolar sufferers forever has been announced.

Applying a concept known as ‘precision medicine’, the breakthrough effectively predicts and targets the treatment of patients based on their genetic profile.

Centre representatives unveiled the discovery and findings from opguy These conditions worsen with the use of antidepressants.

But the concept of precision medicine used a combination of rTMS (Repetitive Transcranial Magnetic Stimulation) and high dose of thyroid hormone, alongside targeted genetic testing for thyroid activating enzymes which ensures the patient suffers minimal, if any side effects.

But this is the first time the technique has been successfully administered in mental health and specifically in bipolar disorder, and there is a belief it could signal a worldwide change in how millions of bipolar disorder sufferers are medically treated in the future.

“There’s every possibility this can have a global impact.”

The London Psychiatry Centre team found through genetic testing that more than 90% of the bipolar cases randomly and consecutively tested have a deficiency of one, two or both enzymes needed to activate thyroid hormone in the brain and the body.

The centre pioneered the effective combination of rTMS and high dose thyroid hormone to specifically target in those sufferers who lack the activating enzymes Deiodinase 1 and Deiodinase 2.

These patients are unable to activate normal doses of thyroid hormone.

The team found that as a result, they can be treated with minimal or no side effects with high dose thyroid and rTMS, but some may need one additional drug as opposed to the usual requirement of a standard of 3 to 4 drugs which, as a rule, cause significant side effects.

Patients who had the combination of rTMS (Repetitive Transcranial Magnetic Stimulation) and high dose thyroid combination saw their condition recover fully after years of unsuccessful treatment with drugs, with the age ranges of patients being between 15 and 80-years-old.

 

 “We hope our findings result in a global transformation of how millions of people are treated for this debilitating illness and signals a reduction in their required medication and side effects.”
Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860